Search Results

There are 6129 results for: content related to: Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer

  1. Trastuzumab-containing regimens for metastatic breast cancer

    Intervention Review

    The Cochrane Library

    Sara Balduzzi, Stefania Mantarro, Valentina Guarneri, Ludovica Tagliabue, Vanna Pistotti, Lorenzo Moja and Roberto D'Amico

    Published Online : 12 JUN 2014, DOI: 10.1002/14651858.CD006242.pub2

  2. You have free access to this content
    Trastuzumab-based neoadjuvant therapy in patients with HER2-positive breast cancer

    Cancer

    Volume 116, Issue 12, 15 June 2010, Pages: 2856–2867, Helena R. Chang

    Article first published online : 1 APR 2010, DOI: 10.1002/cncr.25120

  3. Trastuzumab containing regimens for early breast cancer

    Intervention Review

    The Cochrane Library

    Lorenzo Moja, Ludovica Tagliabue, Sara Balduzzi, Elena Parmelli, Vanna Pistotti, Valentina Guarneri and Roberto D'Amico

    Published Online : 18 APR 2012, DOI: 10.1002/14651858.CD006243.pub2

  4. Management of patients with HER2-positive metastatic breast cancer: Is there an optimal sequence of HER2-directed approaches?

    Cancer

    Amelia B. Zelnak and Kari B. Wisinski

    Article first published online : 23 JUL 2014, DOI: 10.1002/cncr.28815

  5. Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 3, March 2013, Pages: 794–812, Zephania W. Kwong Glover, Lynn Gennaro, Sandeep Yadav, Barthélemy Demeule, Pin Yee Wong and Alavattam Sreedhara

    Article first published online : 5 DEC 2012, DOI: 10.1002/jps.23403

  6. You have free access to this content
    Biomarkers of drugs targeting HER-family signalling in cancer

    The Journal of Pathology

    Volume 232, Issue 2, January 2014, Pages: 219–229, Filippo Montemurro and Maurizio Scaltriti

    Article first published online : 10 DEC 2013, DOI: 10.1002/path.4269

  7. You have full text access to this Open Access content
    Mechanisms of resistance to anti-human epidermal growth factor receptor 2 agents in breast cancer

    Cancer Science

    Volume 102, Issue 1, January 2011, Pages: 1–8, Toru Mukohara

    Article first published online : 6 SEP 2010, DOI: 10.1111/j.1349-7006.2010.01711.x

  8. You have free access to this content
    Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients

    Cancer

    Volume 118, Issue 10, 15 May 2012, Pages: 2603–2614, Eun-Jung Jung, Libero Santarpia, Juyeon Kim, Francisco J. Esteva, Erica Moretti, Aman U. Buzdar, Angelo Di Leo, Xiao-Feng Le, Robert C. Bast Jr, Soon-Tae Park, Lajos Pusztai and George A. Calin

    Article first published online : 5 OCT 2011, DOI: 10.1002/cncr.26565

  9. You have free access to this content
    Signal transduction of erbB receptors in trastuzumab (Herceptin) sensitive and resistant cell lines: Local stimulation using magnetic microspheres as assessed by quantitative digital microscopy

    Cytometry Part A

    Volume 67A, Issue 2, October 2005, Pages: 161–171, Elza Friedländer, Donna J. Arndt-Jovin, Péter Nagy, Thomas M. Jovin, János Szöllősi and György Vereb

    Article first published online : 14 SEP 2005, DOI: 10.1002/cyto.a.20173

  10. You have free access to this content
    Pertuzumab: A New Targeted Therapy for HER2-Positive Metastatic Breast Cancer

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 34, Issue 1, January 2014, Pages: 60–71, Stephanie J. Malenfant, Karen R. Eckmann and Chad M. Barnett

    Article first published online : 5 AUG 2013, DOI: 10.1002/phar.1338

  11. Analysis of neoadjuvant therapies in breast cancer with respect to pathological complete response, disease-free survival and overall survival: 15 years follow-up data from Kuwait

    Asia-Pacific Journal of Clinical Oncology

    Yamini Krishnan, Shafika Al Awadi, P.S Sreedharan, Susovana Sujith Nair and Sanjay Thuruthel

    Article first published online : 12 AUG 2013, DOI: 10.1111/ajco.12118

  12. You have free access to this content
    Systemic treatment of HER2+ metastatic breast cancer: Clinical conundrums and future perspectives

    Asia-Pacific Journal of Clinical Oncology

    Volume 10, Issue S4, June 2014, Pages: 15–25, Richard De Boer, Jane Beith, Jacquie Chirgwin, Sue Chua, Maree Colosimo, Prudence Francis, Michael Green, Ken Pittman, Michelle White, Nicholas Wilcken, Nicholas Zdenkowski and Richard Bell

    Article first published online : 6 MAY 2014, DOI: 10.1111/ajco.12207

  13. Use of trastuzumab in Australia and New Zealand: results from the National Breast Cancer Audit

    ANZ Journal of Surgery

    Volume 82, Issue 4, April 2012, Pages: 234–239, Robert Whitfield, James Kollias, Primali De Silva, Helen Zorbas and Guy Maddern

    Article first published online : 15 JAN 2012, DOI: 10.1111/j.1445-2197.2011.05998.x

  14. You have free access to this content
    Current and emerging targeted therapies for metastatic breast cancer

    Cancer

    Volume 118, Issue 12, 15 June 2012, Pages: 3014–3025, Edith A. Perez and Jean-Philippe Spano

    Article first published online : 17 OCT 2011, DOI: 10.1002/cncr.26356

  15. You have free access to this content
    Systemic treatment of HER2-positive metastatic breast cancer: A systematic review

    Asia-Pacific Journal of Clinical Oncology

    Volume 10, Issue S4, June 2014, Pages: 1–14, Nicholas Wilcken, Nicholas Zdenkowski, Michelle White, Ray Snyder, Ken Pittman, Paul Mainwaring, Michael Green, Prudence Francis, Richard De Boer, Maree Colosimo, Sue Chua, Jacquie Chirgwin, Jane Beith and Richard Bell

    Article first published online : 6 MAY 2014, DOI: 10.1111/ajco.12206

  16. Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2-positive metastatic breast cancer

    Cancer

    Volume 120, Issue 13, 1 July 2014, Pages: 1932–1938, Rashmi K. Murthy, Ankur Varma, Priyankana Mishra, Kenneth R. Hess, Elliana Young, James L. Murray, Kimberly H. Koenig, Stacy L. Moulder, Amal Melhem-Bertrandt, Sharon H. Giordano, Daniel Booser, Vicente Valero, Gabriel N. Hortobagyi and Francisco J. Esteva

    Article first published online : 26 MAR 2014, DOI: 10.1002/cncr.28689

  17. Clinical Experience with Trastuzumab (Herceptin)

    The Breast Journal

    Volume 9, Issue 6, November 2003, Pages: 452–462, Charles L. Vogel and Sandra X. Franco

    Article first published online : 5 NOV 2003, DOI: 10.1046/j.1524-4741.2003.09602.x

  18. ErbB family receptor inhibitors as therapeutic agents in breast cancer: Current status and future clinical perspective

    Medicinal Research Reviews

    Volume 32, Issue 1, January 2012, Pages: 166–215, Ruchi Saxena and Anila Dwivedi

    Article first published online : 25 OCT 2010, DOI: 10.1002/med.20209

  19. You have free access to this content
    Detection, monitoring, and management of trastuzumab-induced left ventricular dysfunction: an actual challenge

    European Journal of Heart Failure

    Volume 14, Issue 2, February 2012, Pages: 130–137, Carlo G. Tocchetti, Gianluca Ragone, Carmela Coppola, Domenica Rea, Giovanna Piscopo, Stefania Scala, Claudia De Lorenzo, Rosario V. Iaffaioli, Claudio Arra and Nicola Maurea

    Article first published online : 18 FEB 2014, DOI: 10.1093/eurjhf/hfr165

  20. You have free access to this content
    Adjuvant targeted therapy in early breast cancer

    Cancer

    Volume 115, Issue 6, 15 March 2009, Pages: 1154–1168, John Mackey, Deanna McLeod, Joseph Ragaz, Karen Gelmon, Sunil Verma, Kathleen Pritchard, Kara Laing, Louise Provencher and Lauren F. Charbonneau

    Article first published online : 22 JAN 2009, DOI: 10.1002/cncr.24114